Abstract
Once the diagnosis of acute gout is made, treatment is generally simple and straightforward. Acute gout is probably the most easily treated of the arthritides, provided that therapy is begun early. Most agents effective in controlling acute gouty inflammation have been in use for years and are well known; several new agents have recently become available (Wallace, 1975). A number of reports on the treatment of acute gout have been published (Goldfinger, 1971; Wallace, 1972; Wyngaarden and Kelley, 1976). Table 1 lists the major drugs that have been used for this purpose in clinical practice. The pharmacology and mechanisms of action of these drugs are less well appreciated, however, and deserve further emphasis, although a series of reviews of the clinical pharmacology of one of these agents, colchicine, has previously been reported (Wallace, 1961, 1965; Wallace and Ertel, 1969; Wallace, 1974). Much new recent information has become available.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Agudelo, C.A., Schumacher, H.R.: The synovitis of acute gouty arthritis: a light and electron microscopic study. Hum. Pathol. 4, 265–279 (1973)
Alvan, G., Orme, M, Bertelsson, L., Ekstrand, R., Palmer, L.: Pharmacokinetics of indomethacin. Clin. Pharmacol. Ther. 18, 364–373 (1975)
Alvares, A.P., Kapelner, S., Sassa, S., Kappas, A.: Drug metabolism in normal children, lead poisoned children, and normal adults. Clin. Pharmacol. Ther. 17, 179–186 (1975)
Arreaza-Plaza, C.A., Bosch, V., Otayek, M.A.: Lipid transport across the intestinal epithelial cell: effect of colchicine. Biochim. Biophys. Acta (Amst.) 431, 297–302 (1976)
Back, A., Walaszek, E.J.: Studies with radioactive colchicine. I. The influence of tumors on the tissue distribution of radioactive colchicine in mice. Cancer Res. 13, 552–555 (1953)
Back, A., Walaszek, E.J., Uyeki, E.: Distribution of radioactive colchicine in some organs of normal and tumor-bearing mice. Proc. Soc. exp. Biol. (N.Y.) 77, 667–669 (1951)
Benitez, H.H., Murray, M.R., Chargaff, E.: Antagonism between colchicine and tropolone in rat fibroblast cultures. Experientia (Basel) 9, 426–427 (1953)
Benitez, H.H., Murray, M.R., Chargaff, E.: Studies of the inhibition of the colchicine effect on mitosis. Ann. N.Y. Acad. Sci. 58, 1288–1302 (1954)
Berlin, R.D.: Temperature dependence of nucleoside membrane transport in rabbit alveolar macrophages and polymorphonuclear leukocytes. J. biol. Chem. 248, 4724–4730 (1973)
Board, J.A.: Effects of colchicine on human ovulation. Amer. J. Obstet. Gynec. 89, 830–831 (1964)
Boardman, P.L., Hart, F.D.: Side effects of indomethacin. Ann. Rheum. Dis. 26, 127–132 (1967)
Borisy, G.G., Taylor, E.W.: The mechanism of action of colchicine. Binding of colchicine-H3 to cellular protein. J. Cell Biol. 34, 525–533 (1967)
Boruchow, I.B.: Bone marrow depression associated with acute colchicine toxicity in the presence of hepatic dysfunction. Cancer 19, 541–543 (1966)
Boudene, C., Duprey, F., Buohon, C.: Radioimmunoassay of colchicine. Biochem. J. 151, 413–415 (1975)
Boyland, E., Mawson, E.H.: The conversion of colchicine into colchiceine. Biochem. J. 32, 1204–1206 (1938)
Bremner, W.J., Paulsen, C.A.: Colchicine and testicular function in man. New Engl. J. Med. 294, 1384–1385(1976)
Brodie, B.B.: Displacement of one drug by another from carrier or receptor sites. Proc. roy. Soc. Med. 58, 946–955 (1965)
Brown, W.O., Seed, L.: Effect of colchicine on human tissues. Amer. J. Clin. Pathol. 15, 189–195 (1945)
Brues, A.M.: The fate of colchicine in the body. J. clin. Invest. 21, 646 (1942)
Brues, A.M.: Discussion of a paper by M. Levine. Ann. N.Y. Acad. Sci. 51, 1406–1408 (1951)
Bruns, B.J.: Colchicine toxicity. Aust. Ann. Med. 17, 341–344 (1968)
Burns, J.J., Rose, R.K., Chenkin, T., Goldman, A., Schulert, A., Brodie, B.B.: The physiologic disposition of phenylbutazone in man, and a method for its estimation in biologic material. J. Pharmacol. exp. Ther. 109, 346–357 (1953)
Burns, J.J., Rose, R.K., Goodwin, S., Reichenthal, J., Horning, E.C., Brodie, B.B.: The metabolic fate of phenylbutazone in man. J. Pharmacol. exp. Ther. 113, 481–489 (1955)
Caner, J.E.Z.: Colchicine inhibition of Chemotaxis. Arthr. and Rheum. 8, 757–761 (1965)
Carr, A.A.: Colchicine toxicity. Arch. intern. Med. 115, 29–33 (1965)
Cestari, A.N., Botelho Viera Filho, J.P., Yonenaga, Y., Magnelli, N., Imada, J.: A case of human reproductive abnormalities induced by colchicine treatment. Rev. Bras. Biol. 25, 253–256 (1965)
Champion, G.D., Paulus, H.E., Mongan, E.: The effect of aspirin on serum indomethacin. Clin. Pharmacol. Ther. 13, 239–244 (1972)
Chang, Y.-H., Gralla, E.J.: Suppression of urate crystal-induced canine joint inflammation by heterologous anti-polymorphonuclear leukocyte serum. Arthr. and Rheum. 11, 145–150 (1968)
Chang, Y.-H., Malawista, S.E.: Mechanism of action of colchicine IV. Failure of non-leukopenic doses of colchicine to suppress urate crystal-induced canine joint inflammation. Inflammation 1, 143–150 (1976)
Cohen, M., McNamara, H.: The effect of colchicine on guinea pig intestinal enzyme activity. Amer. J. dig. Dis. 15, 247–250 (1970)
Conney, A.H.: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19, 317–366 (1967)
Cook, J.W., Loudon, J.D.: The tropolones. Quart. Rev. 5, 99–130 (1951)
Copeman, W.S.C.: A Short History of the Gout and the Rheumatic Diseases. Berkeley-Los Angeles: University of California Press 1964
Crabie, P., Pollet, J., Pebay-Peyroula, F.: Etude de l’hémostase au cours des intoxications aigues par la colchicine. Europ. J. Toxicol. Environ. Hyg. 3, 373–385 (1970)
Cuq, P.: Experience française du traitment de la crise de goutte aigue par le Naproxen. Scand. J. Rheumatol. Suppl. 2, 64–68 (1973)
Davies, D.S., Thorgeirsson, S.S.: Individual differences in plasma half-lives of lipid-soluble drugs in man. Acta Pharmacol. Toxicol. (Kbh.) 29, 181–190 (1971)
Desager, J.P., Vanderbist, M., Harvengt, C.: Naproxen plasma levels in volunteers after single dose administration by oral and rectal routes. J. clin. Pharmacol. 16, 189–193 (1976)
Dewar, M.J.S.: Structure of colchicine. Nature (Lond.) 155, 141–142 (1945)
Dieterle, W., Faigle, J.W., Früh, F, Mory, H., Theobald, W., Alt, K.O., Richter, W.J.: Metabolism of phenylbutazone in man. Arzneimittel-Forsch. 26, 572–577 (1976)
Donker, A.J.M., Arisz, L., Brentjens, J.R.H., Van den Hern, G.K., Hollemans, H.J.G.: Effect of indomethacin on kidney function and plasma renin activity in man. Nephron 17, 288–290 (1976)
Duggan, D.E., Hogans, A.F., Kwan, K.C., McMahon, F.G.: The metabolism of indomethacin in man. J. Pharmacol. exp. Ther. 181, 563–575 (1972)
Ehrlich, H.P., Ross, R., Bornstein, P.: Effect of microtubular agents and secretion of collagen, a biochemical and morphological study. J. Cell Biol. 62, 390–405 (1974)
Eigsti, O.J., Dustin, P., Jr.: Colchicine in Agriculture, Medicine, Biology, and Chemistry. Ames, Iowa: Iowa State College Press 1955
Ellwood, M.G., Robb, G.H.: Self-poisoning with colchicine. Postgrad. med. J. 47, 129–131 (1971)
Emmerson, B.T.: Regimen of indocin therapy in acute gouty arthritis. Br. Med. J. 1967II, 272–274
Emori, W., Paulus, H.E., Bluestone, R., Pearson, C.M.: The pharmacokinetics of indomethacin in serum. Clin. Pharmacol. Ther. 14, 134 (1973)
Ertel, N.H., Mittler, J.C., Akgun, S., Wallace, S.L.: A radioimmunoassay for colchicine in plasma and urine. Science 193, 233–235 (1976)
Ertel, N.H., Wallace, S.L.: Purification of colchicine, its photoisomers and some congeners by paper and thin-layer chromatography. Biochem. Med. 4, 181–192 (1970)
Ertel, N.H., Wallace, S.L.: Measurement of colchicine in urine and peripheral leukocytes. Clin. Res. 19, 348 (1971)
Faloon, W.W.: Drug production of intestinal malabsorption. N.Y. State J. Med. 70, 2189–2192 (1970)
Faloon, W.W., Webb, D.I., Race, T.F.: Cholesterol lowering effect of colchicine. Ann. intern. Med. 66, 1058 (1966)
Feigen, L.P., Klainen, E., Chapnick, B.M., Kadowitz, P.J.: The effect of indomethacin on renal function in pentobarbital anesthetized dogs. J. Pharmacol. exp. Ther. 198, 457–463 (1976)
Ferreira, N.R., Buoniconti, A.: Trisomy after colchicine therapy. Lancet 1968II, 1304
Ferreira, S.H., Moncada, S., Vane, J.R.: Indomethacin and aspirin abolish prostaglandin release from spleen. Nature (Lond.) [New Biol.] 231, 237–239 (1971)
Fitzgerald, T.J.: Molecular features of colchicine associated with antimitotic activity and inhibition of tubulin polymerization. Biochem. Pharmacol. 25, 1383–1387 (1976)
Fitzgerald, T.J., Williams, B., Uyeki, E.: Colchicine on sodium urate-induced paw swelling in mice: structure-activity relationships of colchicine derivatives. Proc. Soc. exp. Biol. (N.Y.) 136, 115–120 (1971)
Fleischman, W., Price, H.G., Fleischman, S.K.: Fate of intraperitoneally administered colchicines in the golden hamster. Med. Pharmacol. Exp. 12, 172–176 (1965)
Fleischman, W., Price, H.G., Fleischman, S.K.: Fate of intraperitoneally administered colchicines in the Mongolian gerbil. Med. Pharmacol. Exp. 17, 323–326 (1967)
Fleischman, W., Price, H.G., Fleischman, S.K.: Pathways of excretion of colchicine in the golden hamster. Pharmacology 1, 48–52 (1968)
Flower, R.J.: Drugs which inhibit prostaglandin synthesis. Pharmacol. Rev. 26, 33–67 (1974)
Forbes, E.J.: Colchicine and related compounds part 14. Structure of B- and γ-lumicolchicine. J. chem. Soc. 3864–3870 (1955)
Franke, W.W., Stadler, J., Krein, S.: Autoradiographic localization of colchicine-binding sites. Beitr. Pathol. 146, 289–291 (1972)
Furcht, L.T., Scott, R.E.: Effect of vinblastine sulfate, colchicine and lumicolchicine on membranous organization of normal and transformed cells. Exp. Cell Res. 96, 271–282 (1975)
Gaultier, M., Kaufer, A., Bismuth, C., Crabie, P., Fréjaville, J.-P.: Données actuelles sur l’intoxication aigue par la colchicine. Ann. Med. Interne 12 605–618 (1969)
Glickman, R.M., Perretto, J.L., Kirsch, K.: Intestinal lipoprotein formation: effect of colchicine. Gastroenterology 70, 347–352 (1976)
Goldfinger, S.E.: Treatment of gout. New Engl. J. Med. 285, 1303–1306 (1971)
Grewe, R., Wolfe, W.: Umwandlung des Colchizins durch Sonnenlicht. Chem. Ber. 84, 621–625 (1951)
Gruber, C.M.: Clinical pharmacology of fenoprofen, a review. J. Rheumatol. Suppl. 2, 8–17 (1976)
Gutman, A.B, Dayton, P.G, Yü, T.-F, Berger, L., Chen, W., Sican, L.E., Burns, J.J.: A study of the inverse relationships between pKa and rate of renal excretion of phenylbutazone analogues in man and dog. Amer. J. Med. 29, 1017–1033 (1960)
Hamberg, M.: Inhibition of prostaglandin synthesis in man. Biophys. Res. Commun. 49, 720–726 (1972)
Harrison, I.T., Lewis, B., Nelson, P., Rooks, W., Roszkowski, A., Tomolonis, A., Fried, J.H.: Nonsteroidal anti-inflammatory agents. I. 6-substituted 2 naphylacetic acids. J. med. Chem. 13, 203–205 (1970)
Hartung, E.F.: History of the use of Colchicum and related medicaments in gout. Ann. rheum. Dis. 13, 190–200 (1954)
Hartung, E.F.: Historical considerations. Metabolism 6, 196–208 (1957)
Heath, D.A., Palmer, J.S., Aurbach, G.D.: The hypocalcemic action of colchicine. Endocrinology 50, 1589–1593 (1972)
Herbst, J.J., Hurwitz, R., Sunshine, P., Kretschmer, N.: The effect of colchicine on intestinal disac-charides: correlation with biochemical aspects of cellular renewal. J. clin. Invest. 49, 530–536 (1970)
Hill, F.W.G.: Malabsorption in dogs induced with oral colchicine. Brit. Vet. J. 128, 372–378 (1972)
Hirsimaki, G., Arstelo, A., Trump, B.F.: Autophagocytosis: in vitro induction by microtubule poisons. Exp. Cell Res. 92, 11–14 (1975)
Ho, P.P.K., Easterman, M.A.: Fenoprofen inhibition of prostaglandin synthesis. Prostaglandins 6, 107–113(1974)
Hucker, H.B., Zacchei, A.G., Cox, S.V., Brodie, D.A., Cantwell, N.H.R.: Studies on the absorption, distribution and excretion of indomethacin in various species. J. Pharmacol. exp. Ther. 153, 237–249 (1966)
Hunter, A.L., Klaasen, C.D.: Biliary excretion of colchicine. J. Pharmacol. exp. Ther. 192, 605–617(1975)
Hvidberg, E.F., Andreasen, P.B., Ranek, L.: Plasma half-life of phenylbutazone in patients with impaired liver function. Clin. Pharmacol. Ther. 15, 171–177 (1974)
Kantor, T.G., Brown, R.: Test of non-specific anti-inflammatory activity of colchicine. Arthr. and Rheum. 9, 862 (1966)
Kaplan, H.: Sarcoid arthritis with a response to colchicine. New Engl. J. Med. 263, 778–781 (1960)
Kaplan, H.: Further experiences with colchicine in the treatment of sarcoid arthritis. New Engl. J. Med. 268, 761–764 (1963)
Kontos, H.A.: Myopathy associated with chronic colchicine toxicity. New Engl. J. Med. 266, 38–39 (1962)
Kuokkanen, K.: Porphyria cutanea tarda due to colchicine in a patient with gout. Acta Derm. Venereol. 51, 318–320 (1971)
Lambert, D.T., Fingerman, M.: Evidence for a non-microtubular effect in pigment granule aggregation in melanophores of the fiddler crab, Uca pugilator. Comp. Biochem. Physiol. [C] 53, 25–28 (1976)
Lettre, H.: Some investigations on cell behavior under various conditions. Cancer Res. 12, 847–860 (1952)
Lettre, H., Lutze, M.: Beitrag zur Verteilung und Wirkung der Colchizine in Tierkörper. Z. physiol. Chem. 281, 58–64 (1944)
Levi, A.J., Sherlock, S., Walker, D.: Phenylbutazone metabolism in patients with liver disease in relation to previous drug therapy. Lancet 1968I, 1275–1279
Lewis, R.J., Trager, W.F., Chan, K.K., Breckenridge, A., Orme, M., Roland, M., Schary, W.: Warfarin: stereochemical aspects of its metabolism and the interaction with phenylbutazone. J. clin. Invest. 53, 1607–1617 (1974)
Lindquist, B., Jensen, K.M., Johansson, H., Hansen, T.: Effect of administration of aspirin and indomethacin on serum concentration. Clin. Pharmacol. Ther. 15, 247–252 (1974)
Linskens, H.F., Wulf, W.: Über die Trennung und Mitosewirkung der Lumicolchicine. Naturwissenschaften 40, 487–488 (1953)
Lockie, L.M.: A discussion of a therapeutic test and a provocative test in gouty arthritis. Ann. intern. Med. 13, 755–760 (1939)
Loudon, J.D.: Chemistry of colchicine. In: Colchicine in Agriculture, Medicine, Biology, and Chemistry. Ames, Iowa: Iowa State College Press 1955
Luketic, G.C., Shapiro, M.: Effect of colchicine on xylose absorption in dogs. Clin. Res. 11, 31 (1964)
McCarty, D.J.: Calcium pyrophosphate crystal deposition disease-1975. Arthr. and Rheum. 19, 275–285 (1976)
McLeod, J.G., Phillips, L.: Hypersensitivity to colchicine. Ann. rheum. Dis. 6, 224–229 (1947)
Malawista, S.E.: Colchicine: a common mechanism for its anti-inflammatory and antimitotic effects. Arthr. and Rheum. 11, 191–197 (1968)
Malawista, S.E.: The action of colchicine in acute gouty arthritis. Arthr. and Rheum. 18, 835–846 (1975)
Malawista, S.E., Bensch, K.G.: Human polymorphonuclear leukocytes: demonstration of microtubules and effect of colchicine. Science 156, 521–522 (1967)
Malawista, S.E., Chang, Y.-H., Wilson, L.: Lumicolchicine: lack of anti-inflammatory effect. Arthr. and Rheum. 15, 641–643 (1972)
Margolis, L.: Colchicine-sensitive microtubules. Int. Rev. Cytol. 34, 333–361 (1973)
Mason, R.W., McQueen, E.G.: Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate in vitro. Pharmacology 12, 12–19 (1974)
Mauer, E.F.: The toxic effects of phenylbutazone. New Engl. J. Med. 253, 404–410 (1955)
Merlin, H.E.: Azospermia caused by colchicine. Fertil. Steril. 23, 180–181 (1972)
Millburn, P.: Factors in the biliary excretion of organic compounds. In: Metabolic Conjugation and Metabolic Hydrolysis, Vol. 2. New York: Academic Press 1970
Mittler, J.C., Ertel, N.H., Akgun, S., Wallace, S.L.: A radioimmunoassay for colchicine in plasma and urine. Clin. Res. 23, 222 (1975)
Mizel, S.B., Wilson, L.: Nucleoside transport in mammalian cells: inhibition by colchicine. Biochemistry 11, 2573–2578 (1972)
Myren, J., Luketic, G.C., Ceballos, R., Sachs, G., Hirschowitz, B.I.: Effects of colchicine on intestinal mucosal disaccharidases. Amer. J. Dig. Dis. 11, 394–403 (1966)
O’Brien, W.M.: Indomethacin: a survey of clinical trials. Clin. Pharmacol. Ther. 9, 94–107 (1968)
Oliver, J.M., Ukena, T.E., Berlin, R.D.: Effects of phagocytosis and colchicine on the lectin-binding sites on cell surfaces. Proc. nat. Acad. Sci. (Wash.) 71, 394–398 (1974)
Ortel, R.W., Newcombe, D.S.: Acute gouty arthritis and response to colchicine in the virtual absence of synovial fluid leukocytes. New Engl. J. Med. 290, 1363–1364 (1974)
Pace-Asciak, C., Cole, S.: Inhibitors of prostaglandin catabolism. Experientia (Basel) 31, 143–145 (1975)
Padawer, J.: Paramitotic effects of colchicine: further studies of the mast cell assay. Proc. Soc. exp. Biol. (N.Y.) 127, 194–199 (1968)
Palmer, L., Bertilsson, L., Alvan, G, Orme, M., Sjogvist, F., Holmstedt, B.: Indomethacin: quantative determination in plasma by mass fragmentography, including pilot pharmaco-kinetics in man. In: Prostaglandin Synthetase Inhibitors. New York: Raven Press 1974
Patak, R.V., Mookerjee, B.K., Bentzel, C.J., Hysert, P.E., Babej, M., Lee, J.B.: Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 10, 649–659 (1975)
Paulus, H.E., Schlosstein, L.H., Godfrey, R.G., Klinenberg, J.R., Bluestone, R.: Prophylactic colchicine therapy of intercritical gout. Arthr. and Rheum. 17, 609–614 (1974)
Pelletier, P.J., Caventou, J.-B.: Examen chimique de plusiers vegetaux de la famille des colchicées et du principe actif qu’ils renferment. Ann. Chim. Phys. 14, 69–83 (1820)
Perry, K., Jonen, H.G., Kahl, G.F., Jähnshen, E.: Elimination and distribution of phenylbutazone in rats during the course of adjuvant-induced arthritis. J. Pharmacol, exp. Ther. 197, 470–477 (1976)
Pesanti, E.L., Axline, S.G.: Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage. J. exp. Med. 141, 1030–1046 (1975)
Phelps, P.: Polymorphonuclear leukocyte motility in vitro. II. Stimulatory effect of monosodium urate crystals and urate in solution. Arthr. and Rheum. 12, 189–196 (1969)
Phelps, P.: Appearance of chemotactic activity following intraarticular injection of monosodium urate crystals: effect of colchicine. J. Lab. clin. Med. 76, 622–631 (1970a)
Phelps, P.: Polymorphonuclear leukocyte activity in vitro IV. Arthr. and Rheum. 13, 1–9 (1970b)
Phelps, P., McCarty, D.J.: Crystal-induced inflammation in canine joints. II. Importance of polymorphonuclear leukocytes. J. exp. Med. 124, 115–126 (1966)
Phelps, P., McCarty, D. J.: Crystal induced arthritis. Postgrad. med. 45, 87–93 (1969)
Powell, H.C., Wolf, P.L.: Neutrophilic leukocyte inclusions in colchicine intoxication. Arch. Path. Lab. Med. 100, 136–138 (1976)
Prescott, L.F.: Pharmocokinetic drug interactions. Lancet 1969II, 1239–1243
Race, T.F., Paes, I.C., Faloon, W.W.: Intestinal malabsorption induced by oral colchicine. Amer. J. Med. Sci. 259, 32–41 (1970)
Redman, C.M., Benerjee, D., Howell, K., Palade, G.E.: Colchicine inhibition of plasma protein release from rat hepatocytes. J. Cell Biol. 66, 42–59 (1975)
Richter, W.J, Alt, K.O, Dieterle, W, Faigle, J.W, Kriemler, H.-P, Mory, H., Winkler, T.: C-glucuronides, a novel type of drug metabolite. Helv. chim. Acta 58, 2512–2517 (1975)
Robinson, D.R, Levine, L.: Prostaglandin concentrations in synovial fluid in rheumatic diseases: action of indomethacin and aspirin. In: Prostaglandin Synthetase Inhibitors. New York: Raven Press 1974
Roszkowski, A.P, Rooks, W.H, Tomolonis, A.J, Miller, L.M.: Anti-inflammatory and analgetic properties of d-2-(61-methoxy-21-naphthyl)-propionic acid (naproxen). J. Pharmacol. exp. Ther. 179, 114–123 (1971)
Rubin, A, Chernish, S.M, Crabtree, R, Gruber, C.M., Helleberg, L., Rodda, B.E., Warrick, P., Wolen, R.L., Ridolfo, A.S.: A profile of the physiologic disposition and gastrointestinal effects of fenoprofen in man. Curr. Med. Res. Opin. 2, 529–544 (1974)
Rubin, A., Rodda, B.E., Warrick, P., Ridolfo, A.S., Gruber, C.M.: Physiologic disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration. J. Pharm. Sci. 61, 739–745 (1972)
Rubulis, A., Rubert, M., Faloon, W.W.: Cholesterol lowering, fecal bile acid and sterol changes during neomycin and colchicine. J. clin. Nutr. 23, 1251–1259 (1970)
Rumpf, K.W., Frenzel, S., Lowitz, H.D., Scheler, F.: The effect of indomethacin on plasma renin activity in man under normal conditions and after stimulation of the renin-angiotensin system. Prostaglandins 10, 641–648 (1975)
Runkel, R., Forchielli, E., Boost, G., Chaplin, M., Hill, R., Sevelius, H., Thompson, G., Segre, E.: Naproxen metabolism, excretion and comparative pharmacokinetics. Scand. J. Rheumatol. Suppl. 2, 29–36 (1973)
Sagorin, C., Ertel, N.H., Wallace, S.L.: Photoisomerization of colchicine. Loss of significant antimitotic activity in tissue culture. Arthr. and Rheum. 15, 213–217 (1972)
Schary, W.L, Lewis, R.J, Rowland, M.: Warfarin-phenylbutazone interaction in man: a long-term multiple dose study. Res. Commun. Chem. Pathol. Pharmacol. 10, 663–672 (1975)
Schoenharting, M, Mende, G, Siebert, G.: The metabolic transformation of colchicine. II. The metabolism of colchicine by mammalian liver microsomes. Hoppe-Seylers Z. physiol. Chem. 355, 1391–1399(1974)
Schoenharting, M., Pfaender, P., Ricker, A, Siebert, G.: The metabolic transformation of colchicine. I. The oxidative formation of products from colchicine in the Udenfriend system. Hoppe-Seylers Z. physiol. Chem. 354, 421–436 (1973)
Segre, E.J.: Naproxen metabolism in man. J. Clin. Pharmacol. 15, 316–323 (1975)
Segre, E.J, Runkel, R., Chaplin, M., Sevelius, H., Forchielli, E.: Naproxen-aspirin interactions in man. Clin. Pharmacol. Ther. 15, 374–379 (1974)
Sharma, J.N, Zeitlin, I.J., Brooks, P.M., Dick, W.C.: Raised plasma kininogen levels in rheumatoid arthritis. Response to indomethacin and relationship to clinical indices. Ann. rheum. Dis. 34, 464 (1975)
Sjöhalin, I.S., Sjödin, T.: Binding of drugs to human serum albumin. Biochem. Pharmacol. 21, 3041–3052 (1972)
Skeith, M.D., Simkin, P.A., Healey, L.A.: The renal excretion of indomethacin and its inhibition by probenecid. Clin. Pharmacol. Ther. 9, 89–93 (1968)
Smyth, C.J.: Indomethacin—its rightful place in treatment. Ann. intern. Med. 72, 430–432 (1970)
Smyth, C.J, Frank, L.S.: Treatment of acute gouty arthritis. Rheumatism. 18, 2–8 (1962)
Solberg, C.O.: Influence of therapeutic concentrations of phenylbutazone on granulocyte function. Acta path, microbiol. scand. B83, 100–104 (1975)
Solomon, H.M., Schrogie, J.J.: The effect of various drugs on the binding of warfarin-C14 to human albumin. Biochem. Pharmacol. 16, 1219–1226 (1967)
Solomon, H.M., Schrogie, J.J., Williams, D.: The displacement of phenybutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids. Biochem. Pharmacol. 17, 143–151(1968)
Spilberg, I., Mandell, B., Wochner, R.D.: Studies in crystal induced chemotactic factor. J. Lab. clin. Med. 83, 56–63 (1974)
Stadler, J., Franke, W.W.: Colchicine-binding proteins in chromatin and membranes. Nature (Lond.) New Biol. 237, 237–238 (1972)
Stadler, J., Franke, W.W.: Characterization of the colchicine binding of membrane fractions from rat and mouse liver. J. Cell Biol. 60, 297–303 (1974)
Stennerman, G.N., Hayashi, T.: Colchicine intoxication: a reappraisal of its pathology based on a study of three fatal cases. Hum. Pathol. 2, 321–332 (1971)
Sczeklik, A., Gryglewski, R.J., Czerndawski-Mysik, G., Zmuda, A.: Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation. J. Allergy Clin. Immunol. 58, 10–18 (1976)
Thompson, G.R., Ting, Y.M., Riggs, G.A.: Calcific tendonitis and soft tissue calcification resembling gout. J. Amer. med. Ass. 203, 464–472 (1968)
Tomlinson, R.V., Ringold, H., Quereshi, M.C., Forchielli, E.: Relationship between inhibition of prostaglandin synthesis and drug efficacy. Biochim. Biophys. Res. Commun. 45, 552–559 (1972)
Ukena, T.D., Berlin, R.D.: Effect of colchicine and vinblastine on the topographical separation of membrane functions. J. exp. Med. 136, 1–7 (1972)
Vane, J.R.: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (Lond.) New Biol. 231, 232–235 (1971)
Van Petten, A.R., Feng, H., Withey, R.J., Littau, H.F.: The physiologic availability of solid dosage forms of phenylbutazone. J. Clin. Pharmacol. 11, 177–186 (1971)
Vesell, E.S., Page, J.G.: Genetic control of drug levels in man: phenylbutazone. Science 159, 1479–1480(1968)
Vesell, E.S., Passananti, G.T., Johnson, A.O.: Failure of indomethacin and warfarin to interact in normal human volunteers. J. Clin. Pharmacol. 15, 486–495 (1975)
Walaszek, E.J., Kelsey, F.E., Geiling, E.M.K.: Biosynthesis and isolation of radioactive colchicine. Science 116, 225–227 (1952)
Walaszek, E.J, Kocsis, J.J.: Excretion of 14C labelled colchicine. Fed. Proc. 15, 495 (1956)
Walaszek, E.J., Kocsis, J.J., LeRoy, G.V., Geiling, E.M.K.: Studies on the excretion of radioactive colchicine. Arch. int. Pharmacodyn. Ther. 125, 371–382 (1960)
Walaszek, E.J., LeRoy, G.V., Geiling, E.M.K.: Renal excretion of radioactive colchicine in patients with and without neoplastic disease. Fed. Proc. 13, 413 (1954)
Waldi, D., Schnackerz, K., Munter, F.: Eine systematische Analyse von Alkaloiden auf Dünnschichtplatten. J. Chromatog. 6, 61–73 (1961)
Wallace, S.L.: Colchicine analogues in the treatment of acute gout. Arthr. and Rheum. 2, 389–395 (1959)
Wallace, S.L.: Colchicine: clinical pharmacology in acute gouty arthritis. Amer. J. Med. 30, 439–448 (1961)
Wallace, S.L.: Mechanism of action of colchicine. Arthr. and Rheum. 8, 744–748 (1965)
Wallace, S.L.: The treatment of gout. Arthr. and Rheum. 15, 317–323 (1972)
Wallace, S.L.: Colchicum. The panacea. Bull. N.Y. Acad. Med. 40, 130–135 (1973)
Wallace, S.L.: Colchicine. Semin. Arthr. and Rheum. 3, 369–381 (1974)
Wallace, S.L.: Colchicine and new anti-inflammatory drugs in the treatment of acute gout. Arthr. and Rheum. 18, 847–850 (1975 a)
Wallace, S.L.: Gout and hypertension. Arthr. and Rheum. 18, 721–725 (1975b)
Wallace, S.L., Bernstein, D., Diamond, H.: Diagnostic value of the colchicine therapeutic trial. J. Amer. med. Ass. 199, 525–528 (1967)
Wallace, S.L., Ertel, N.H.: Colchicine: current problems. Bull. rheum. Dis. 20, 582–587 (1969)
Wallace, S.L., Ertel, N.H.: Plasma levels of colchicine after oral administration of a single dose. Metabolism 22, 749–753 (1973)
Wallace, S.L., Omokoku, B., Ertel, N.H.: Colchicine plasma levels. Implications as to pharmacology and mechanism of action. Amer. J. Med. 48, 443–448 (1970)
Wanasukapunt, S., Lertratanakul, Y., Rubenstein, H.M.: Effect of fenoprofen calcium on acute gouty arthritis. Arthr. and Rheum. 19, 933–935 (1976)
Webb, D.I., Chodos, R.B., Maher, C.Q., Faloon, W.W.: Mechanism of vitamin B12 malabsorption in patients receiving colchicine. New Engl. J. Med. 279, 845–850 (1968)
Weiner, M., Chenkin, T., Burns, J.J.: Observations on the metabolic transformation and effects of phenylbutazone in subjects with hepatic disease. Amer. J. Med. Sci. 228, 36–39 (1954)
Wildman, W.C., Pursey, B.A.: Colchicine and related compounds. In: The Alkaloids, Vol. II. New York: Academic Press 1968
Willkens, R.F., Case, J.B.: Treatment of acute gout with naproxen. Scand. J. Rheumatol. Suppl. 2, 69–71 (1973)
Willkens, R.F., Case, J.B., Huix, F.J.: The treatment of acute gout with naproxen. J. clin. Pharmacol. 15, 363–366 (1976)
Wilson, L., Bryan, J.: Biochemical and pharmacologic properties of microtubules. In: Advances in Cell and Molecular Biology. New York: Academic Press 1974
Wilson, L., Friedkin, M.: The biochemical events of mitosis. I. Synthesis and properties of colchicine labelled with tritium in its acetyl moiety. Biochemistry 5, 2463–2468 (1966)
Wilson, L., Friedkin, M.: The biochemical events of mitosis. II. The in vivo and in vitro binding of colchicine in grasshopper embryos and its possible relation to the inhibition of mitosis. Biochemistry 6, 3126–3135 (1967)
Woodward, R.B.: A total synthesis of colchicine. In: The Harvey Lectures, Series 59. New York-London: Academic Press 1967
Wunderlich, F., Müller, R., Speth, V.: Direct evidence for a colchicine-induced impairment in the mobility of membrane components. Science 182, 1136–1138 (1973)
Wyngaarden, J.B., Kelley, W.N.: Gout and Hyperuricemia. New York: Grune and Stratton 1976
Yü, T.-F., Burns, J.J., Paton, B.C., Gutman, A.B., Brodie, B.B.: Phenylbutazone metabolites; antirheumatic, sodium-retaining, and uricosuric effects in man. J. Pharmacol. exp. Ther. 123, 63–69 (1958)
Yü, T.-F., Gutman, A.B.: Efficacy of colchicine prophylaxis. Ann. intern. Med. 55, 179–192 (1961)
Zweig, M.H., Maling, H.M., Webster, M.E.: Inhibition of sodium urate rat hind paw edema by colchicine derivatives. Correlation with antimitotic activity. J. Pharmacol. exp. Ther. 182, 344–350 (1972)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wallace, S.L., Ertel, N.H. (1978). Pharmacology of Drugs Used in Treatment of Acute Gout. In: Kelley, W.N., Weiner, I.M. (eds) Uric Acid. Handbook of Experimental Pharmacology, vol 51. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66867-8_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-66867-8_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66869-2
Online ISBN: 978-3-642-66867-8
eBook Packages: Springer Book Archive